The global swine healthcare market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.15%
Last updated
IMARC Group’s report titled “Swine Healthcare Market Report by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2025-2033”. The global swine healthcare market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.15% during 2025-2033.
Factors Affecting the Growth of the Swine Healthcare Industry:
● Rising Incidence of Swine Diseases:
Disease outbreaks like African Swine Fever, PRRS, and Swine Influenza are rising. This increases the demand for vaccines and treatments. Farmers and swine producers are now investing more in healthcare products to protect their herds. They aim to reduce disease risks. The need for advanced diagnostic tools is also growing. These tools should quickly and accurately detect pathogens. Early detection is vital for controlling diseases. It prevents their spread. This situation is boosting innovation and investment in diagnostic technologies and services.
● Advancements in Veterinary Medicine:
New vaccine technologies are making swine vaccines safer and more effective. These improvements aid in preventing diseases, lowering death rates, and boosting herd health. Also, advanced tools like PCR tests and rapid antigen kits allow for faster, more accurate disease detection. Early and correct diagnosis enables timely treatment, reducing outbreak impacts.
● Growing Awareness Among Farmers:
Farmers are now more aware of preventive healthcare. This awareness leads them to adopt vaccinations, health checks, and biosecurity. Such measures help detect and prevent diseases early. Consequently, this reduces illness rates. As farmers learn about the benefits of quality healthcare products, they invest more in vaccines, medications, and diagnostic tools. This shift improves the health and productivity of swine herds.
Grab a sample PDF of this report: https://www.imarcgroup.com/swine-healthcare-market/requestsample
Leading Companies Operating in the Global Swine Healthcare Industry:
Boehringer Ingelheim International GmbH
Ceva Animal Health Inc.
Elanco
IDEXX Laboratories Inc.
Innovative Diagnostic
Merck & Co. Inc.
Phibro Animal Health Corporation
Vetoquinol
Virbac Corporation
Zoetis Inc.
Swine Healthcare Market Report Segmentation:
By Product:
Diagnostic Tests
Enzyme Linked Immuno-Sorbent Assay (ELISA)
Rapid Immuno Migration (RIM)
Agar Gel Immuno-Diffusion (AGID)
Polymerase Chain Reaction (PCR)
Diagnostic Imaging
Others
Therapeutics
Vaccines
Parasiticides
Anti-infectives
Feed Additives
Others
Therapeutics represent the largest segment due to the high incidence of infectious diseases and the need for effective treatment solutions.
By Disease:
Exudative Dermatitis
Coccidiosis
Respiratory Diseases
Swine Dysentery
Porcine Parvovirus
Others
Respiratory diseases account for the majority of the market share. Respiratory diseases are prevalent and pose severe threats to swine health and productivity, necessitating substantial investment in preventive and therapeutic measures.
By Route of Administration:
Injectable
Oral
On the basis of the route of administration, the market has been bifurcated into injectable and oral.
By Distribution Channel:
Veterinary Hospitals
Retail Pharmacy
Online Pharmacy
Based on the distribution channel, the market has been divided into veterinary hospitals, retail pharmacy and online pharmacy.
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America enjoys the leading position in the swine healthcare market on account of its advanced veterinary infrastructure, high awareness of animal health, and substantial investments in R&D.
Global Swine Healthcare Market Trends:
The market is seeing a rise in advanced diagnostic tests, like PCR and ELISA, which allow for quick and accurate disease detection. This enables timely intervention. Moreover, there's a growing focus on preventive healthcare. Investments are increasing in vaccines for swine diseases such as ASF and PRRS. Technologies for precision livestock farming, including health monitoring and data analysis, are improving disease management and herd health. This is boosting market growth. Additionally, swine production is rapidly growing in Asia-Pacific and Latin America. This surge is increasing the demand for comprehensive swine healthcare solutions.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US
IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States: +1–631–791–1145
